
Neuland Laboratories Ltd is Rated Buy
2026-07-27 10:10:04Neuland Laboratories Ltd is rated Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 27 July 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleWhen is the next results date for Neuland Laboratories Ltd?
2026-07-21 23:16:49Neuland Laboratories Ltd is scheduled to declare its results on 05 August 2026....
Read full news article
Neuland Laboratories Ltd is Rated Buy
2026-07-16 10:10:04Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
Broad-Based Technical Strength Lifts Neuland Laboratories Ltd to 52-Week High of Rs 19800
2026-07-09 13:05:15Surging past its previous peaks, Neuland Laboratories Ltd touched a fresh 52-week high of Rs 19,800 on 9 Jul 2026, marking a remarkable 66.16% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and robust quarterly earnings growth, setting the stage for a sustained uptrend.
Read full news article
Neuland Laboratories Ltd is Rated Buy
2026-07-05 10:10:05Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Neuland Laboratories Ltd is Rated Buy
2026-06-24 10:10:04Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news article
Neuland Laboratories Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals
2026-06-24 08:00:44Neuland Laboratories Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators that suggest a strengthening uptrend. The stock’s recent performance, coupled with upgraded technical grades and a robust Mojo Score, positions it favourably within the Pharmaceuticals & Biotechnology sector.
Read full news article
Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-06-16 08:01:05Neuland Laboratories Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early June 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, and moving averages reveal a complex interplay of signals that investors should carefully analyse amid the broader Pharmaceuticals & Biotechnology sector dynamics.
Read full news articleNeuland Laboratories Limited - Registrar & Share Transfer Agent Update
09-Dec-2019 | Source : NSENeuland Laboratories Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update- Change in name of Registrar & Share Transfer Agent of the Company.
Neuland Laboratories Limited - Other General Purpose
27-Nov-2019 | Source : NSENeuland Laboratories Limited has submitted to the Exchange a copy of half yearly disclosure on Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Neuland Laboratories Limited - Press Release
15-Nov-2019 | Source : NSENeuland Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled "Press Release".
Corporate Actions
05 Aug 2026
Neuland Laboratories Ltd has declared 340% dividend, ex-date: 24 Jul 26
No Splits history available
No Bonus history available
Neuland Laboratories Ltd has announced 4:25 rights issue, ex-date: 13 Aug 14







